ArticleSignal transduction and targeted therapy2021

Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy.

Fengzhen Mo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.